0001140361-12-033917.txt : 20120725 0001140361-12-033917.hdr.sgml : 20120725 20120725152334 ACCESSION NUMBER: 0001140361-12-033917 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120723 FILED AS OF DATE: 20120725 DATE AS OF CHANGE: 20120725 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wood Mark CENTRAL INDEX KEY: 0001401782 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 12978832 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2012-07-23 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001401782 Wood Mark C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949 0 1 0 0 VP, Human Resources Common Stock 2012-07-23 2012-07-23 4 M 0 813 26.49 A 33177 D Common Stock 2012-07-23 2012-07-23 4 M 0 83 17.86 A 33260 D Common Stock 2012-07-23 2012-07-23 4 M 0 937 14.39 A 34197 D Common Stock 2012-07-23 2012-07-23 4 M 0 833 21.51 A 35030 D Common Stock 2012-07-23 2012-07-23 4 S 0 2666 39.2473 D 32364 D Stock Option (right to buy) Common Stock 26.49 2012-07-23 2012-07-23 4 M 0 813 0 D 2011-11-12 2021-05-11 Common Stock 813 122693 D Stock Option (right to buy) Common Stock 17.86 2012-07-23 2012-07-23 4 M 0 83 0 D 2009-06-17 2018-12-16 Common Stock 83 122610 D Stock Option (right to buy) Common Stock 14.39 2012-07-23 2012-07-23 4 M 0 937 0 D 2009-11-12 2019-05-11 Common Stock 937 121673 D Stock Option (right to buy) Common Stock 21.51 2012-07-23 2012-07-23 4 M 0 833 0 D 2010-11-12 2020-05-11 Common Stock 833 120840 D Transaction made pursuant to a Rule 10b5-1 Trading plan executed on August 10, 2011. The price in Column 4 is a weighted average price. The prices actually received ranged from $39.02 to $39.75. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Original option grant vests 6/48th on November 12, 2011 and 1/48th each on the 12th of each month thereafter. Original option grant vests 6/48th on June 17, 2009 and 1/48th each on the 17th of each month thereafter. Original option grant vests 6/48th on November 12, 2009 and 1/48th each on the 12th of each month thereafter. Original option grant vests 6/48th on November 12, 2010 and 1/48th each on the 12th of each month thereafter. /s/ Laura Randall Woodhead, Attorney-in-Fact 2012-07-25